Status:
RECRUITING
The Swiss Neurodevelopmental Outcome Registry for Children With CHD
Lead Sponsor:
University Children's Hospital, Zurich
Collaborating Sponsors:
University of Lausanne Hospitals
University of Geneva, Switzerland
Conditions:
Neurodevelopmental Abnormality
Congenital Heart Disease
Eligibility:
All Genders
1-6 years
Brief Summary
Introduction: Congenital heart disease (CHD) is the most frequent birth defect. As survival has significantly improved, attention has turned to neurodevelopmental outcomes of children undergoing heart...
Eligibility Criteria
Inclusion
- Neonates (including preterm born children) with severe CHD
- Requiring an invasive cardiac intervention (including heart-lung-machine) within the first 6 weeks of life.
Exclusion
- Neonates (including preterm born children) with simple CHD
- Requiring simple cardiac surgery or catheter intervention such as closure of patent arterial duct or simple repair of aortic coarctation without heart-lung-machine and low impact on neurodevelopmental outcome.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05996211
Start Date
January 1 2019
End Date
December 31 2032
Last Update
August 18 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bern
Bern, Switzerland
2
University of Lausanne
Lausanne, Switzerland
3
University Children's Hospital
Zurich, Switzerland, 8032